Literature DB >> 8551217

Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction.

J F Maddox1, C N Serhan.   

Abstract

Monocyte recruitment and adherence are important events in inflammatory and vascular diseases. Here, we evaluated the actions of lipoxin A4 (LXA4) and LXB4, a series of lipoxygenase products from arachidonic acid generated by cell-cell interactions, on human monocytes. LXA4 and LXB4 (10(-7) M) each increased monocyte migration in chamber chemotaxis assays and, in migration under agarose, exhibited chemotactic indices similar to those of the chemotactic peptide formyl-methionyl-leucyl-phenylalanine at 10(-10)-10(-8) M and to the chemokine macrophage inflammatory protein-1 alpha (MIP-1 alpha) at 10(-8)-10(-7) M with a rank order of potency: Monocyte chemotactic protein-1 alpha > LXA4 approximately LXB4 approximately MIP-1 alpha. Lipoxins also stimulated monocyte adherence to laminin. In addition, human monocytes rapidly transformed LXA4 and LXB4 to several metabolites. LXB4 (> 80%) was converted within 30 s to new products, in a trend similar to that of LXA4. The novel monocyte-derived LXB4 products were identified as 5-oxo-6,7-dihydro-LXB4 and 6,7-dihydro-LXB4, indicating a role for site-selective dehydrogenation and reduction. Unlike monocytes, intact polymorphonuclear leukocytes (PMN) did not metabolize LXA4 in significant quantities, and only approximately 12% of exogenous LXB4 was omega-oxidized to 20-OH-LXB4 and 20-COOH-LXB4 by PMN. To determine if lipoxin conversion altered bioactivity, we evaluated the actions of these metabolites on monocytes. Each of the novel products of LXA4 and LXB4 from monocytes, namely oxo- and dihydrolipoxins, were essentially inactive in stimulating monocyte adherence. In contrast, the omega-oxidation products of LXB4 isolated from PMN were equipotent with LXB4 for monocyte adherence. Dehydrogenation of LXA4 in monocytes appears to be carried out by a 15-hydroxyprostaglandin dehydrogenase, which is present in human monocytes as determined by reverse transcription PCR and Western blots. Together, these results provide the first evidence that LXA4 and LXB4 are both potent stimulants for migration and adherence of human monocytes. Moreover, they underscore the importance of the major route of lipoxin metabolism in leukocytes, namely, the rapid dehydrogenation and inactivation carried out by monocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551217      PMCID: PMC2192402          DOI: 10.1084/jem.183.1.137

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  Defective in vitro motility of polymorphonuclear leukocytes of homozygote and heterozygote Chediak-Higashi cats.

Authors:  S P Colgan; A M Blancquaert; M A Thrall; W J Bruyninckx
Journal:  Vet Immunol Immunopathol       Date:  1992-03       Impact factor: 2.046

2.  Cyclooxygenase gene expression is down-regulated by heparin-binding (acidic fibroblast) growth factor-1 in human endothelial cells.

Authors:  T Hla; T Maciag
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Effects of novel leukotrienes on neutrophil migration.

Authors:  J Palmblad; A M Udén; J A Lindgren; O Rådmark; G Hansson; C L Malmsten
Journal:  FEBS Lett       Date:  1982-07-19       Impact factor: 4.124

6.  Characterisation of the under-agarose method for quantifying migration of highly purified human monocytes.

Authors:  A M Al-Sumidaie; D L Jones; H L Young
Journal:  J Immunol Methods       Date:  1984-12-14       Impact factor: 2.303

7.  Identification and biological activity of novel omega-oxidized metabolites of leukotriene B4 from human leukocytes.

Authors:  G Hansson; J A Lindgren; S E Dahlén; P Hedqvist; B Samuelsson
Journal:  FEBS Lett       Date:  1981-07-20       Impact factor: 4.124

8.  A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration.

Authors:  W Falk; R H Goodwin; E J Leonard
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

9.  Metabolism of 5(S)-hydroxy-6,8,11,14-eicosatetraenoic acid and other 5(S)-hydroxyeicosanoids by a specific dehydrogenase in human polymorphonuclear leukocytes.

Authors:  W S Powell; F Gravelle; S Gravel
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

10.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

View more
  92 in total

1.  The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?

Authors:  Sesquile Ramon; Steven F Baker; Julie M Sahler; Nina Kim; Eric A Feldsott; Charles N Serhan; Luis Martínez-Sobrido; David J Topham; Richard P Phipps
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 2.  Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?

Authors:  Charles N Serhan
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

Review 3.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

Review 4.  Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.

Authors:  Charles N Serhan
Journal:  FASEB J       Date:  2017-01-13       Impact factor: 5.191

Review 5.  Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.

Authors:  Charles N Serhan
Journal:  Mol Aspects Med       Date:  2017-03-03

Review 6.  Endogenous lipid mediators in the resolution of airway inflammation.

Authors:  O Haworth; B D Levy
Journal:  Eur Respir J       Date:  2007-11       Impact factor: 16.671

Review 7.  Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.

Authors:  C N Serhan; N Chiang
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 8.  Anti-inflammatory and proresolving lipid mediators.

Authors:  Charles N Serhan; Stephanie Yacoubian; Rong Yang
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

9.  Resolvin E1 and protectin D1 activate inflammation-resolution programmes.

Authors:  Jan M Schwab; Nan Chiang; Makoto Arita; Charles N Serhan
Journal:  Nature       Date:  2007-06-14       Impact factor: 49.962

Review 10.  A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution.

Authors:  Charles N Serhan
Journal:  Histochem Cell Biol       Date:  2004-08-21       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.